---
title: "Weekly Recap | Lichen -94.26%, reverse split and offering priced"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305536037.md"
description: "Lichen (LICN) fell 94.26% this week to close at $0.0293. The S&P 500 rose 2.51% over the same period, leaving the stock roughly 96.77 percentage points behind the benchmark. Day by day, the stock opened Monday at $0.2926 and touched a high of $0.3804 before gapping down to $0.0489 on Tuesday, then drifted lower through Wednesday, Thursday and Friday. Friday’s low of $0.0286 marked the week’s bottom, with a close of $0.0293."
datetime: "2026-11-14T06:39:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305536037.md)
  - [en](https://longbridge.com/en/news/305536037.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305536037.md)
generator: "portal-rs"
---

# Weekly Recap | Lichen -94.26%, reverse split and offering priced

## The Week

Lichen (LICN) fell 94.26% this week to close at $0.0293. The S&P 500 rose 2.51% over the same period, leaving the stock roughly 96.77 percentage points behind the benchmark. Day by day, the stock opened Monday at $0.2926 and touched a high of $0.3804 before gapping down to $0.0489 on Tuesday, then drifted lower through Wednesday, Thursday and Friday. Friday’s low of $0.0286 marked the week’s bottom, with a close of $0.0293. The shape of the week was a sharp early spike followed by a one-way slide.

## Key Events

The main thread this week was a reverse split and capital raising. Early in the week Lichen hit a new 52-week low in pre-market trading. On Tuesday the company held an extraordinary shareholder meeting, approved a 1-for-100 reverse stock split, and announced a $3.5 million registered direct offering. The stock fell nearly 84% intraday following the news. It bounced 37% after hours on Wednesday and rose 27% in the pre-market session, before sliding back, falling 17% intraday on Thursday and another 14% on Friday as the company priced the $3.5 million direct offering and hit a record low. The week’s substantive filing was a 424B5 submitted on 11 November, tied to the direct offering pricing.

## The Week Ahead

Macro data next week runs from 16 to 17 November, including the New York Fed manufacturing index, import prices, retail sales, industrial production and the NAHB housing market index, which can serve as a gauge for overall market tone. On the company side, the next scheduled event is fiscal Q3 2026 earnings on 18 December after the close, still some weeks away. The near-term focus is the execution of the reverse split and the $3.5 million direct offering, as well as whether the new share structure stabilises trading conditions.

## In Short

Lichen’s move this week was closely tied to its own corporate actions: the reverse split approval and the pricing of a $3.5 million direct offering accompanied a slide from $0.2926 to around $0.0293. The latest session’s fund flow showed large and medium orders on the sell side. On valuation, the price-to-book sat at $0.010, reflecting an extremely compressed market price for the company’s assets. What to watch next is how the reverse split alters trading dynamics, whether the offering proceeds land as planned, and how macro data shapes risk appetite from here.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [LICN.US](https://longbridge.com/en/quote/LICN.US.md)

## Related News & Research

- [Lichen International Prices $3.5 Million Registered Direct Offering](https://longbridge.com/en/news/305376050.md)
- [Lichen International announces $3.5M registered direct offering; shares tumble](https://longbridge.com/en/news/305019992.md)
- [Cadence Design Systems (CDNS) Launches New AI Tools, Is It Still 20% Undervalued?](https://longbridge.com/en/news/305521888.md)
- [Micron Stock (MU) Forecast – Why Are Analysts Bullish Despite Ongoing Volatility?](https://longbridge.com/en/news/305555924.md)
- [Opendoor Technologies (OPEN) Drew Fresh Bearish Bets Following Earnings, Is It Still 57% Undervalued?](https://longbridge.com/en/news/305521966.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**